acadia pharmaceuticals inc
(ACAD:Consolidated Issue Listed on NASDAQ Global Select )
Roger G. Mills M.D.
Chief Medical Officer and Executive Vice President of Development, ACADIA Pharmaceuticals Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
As of Fiscal Year 2013
Dr. Roger G. Mills, M.D. has been an Executive Vice President of Development at Acadia Pharmaceuticals Inc., since June 30, 2006 and also serves as its Chief Medical Officer. Dr. Mills is responsible for leading ACADIA's global drug development activities. He has more than 18 years of experience in the pharmaceutical industry. He served as Vice President of Development at Pfizer Global R&D, a division of Pfizer Inc., for a five-year period. He was responsible for the ...
11085 Torreyana RoadPhone: 858-558-2871
San Diego, California 92121
Board Members Memberships*There is no Board Members Memberships data available.
Charing Cross & Westminster Medical School London
|Ron Cohen M.D.||Founder, Chief Executive Officer, President and Director|
Acorda Therapeutics, Inc.
|Stanley T. Crooke M.D., Ph.D.||Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee|
Isis Pharmaceuticals, Inc.
|Keith A. Katkin||Chief Executive Officer, President, Director and Member of Executive Committee|
Avanir Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|George Frederick Wilkinson||Chief Executive Officer, President and Director|
Impax Laboratories Inc.
|--||Compensation as of Fiscal Year 2013.|